These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34187692)

  • 1. The landmark contributions of Paul Blocq, Georges Marinesco, and Édouard Brissaud in Parkinson's disease.
    Fénelon G; Walusinski O
    Rev Neurol (Paris); 2021 Dec; 177(10):1214-1220. PubMed ID: 34187692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substantia nigra and Parkinson's disease: a brief history of their long and intimate relationship.
    Parent M; Parent A
    Can J Neurol Sci; 2010 May; 37(3):313-9. PubMed ID: 20481265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shake the Disease. Georges Marinesco, Paul Blocq and the Pathogenesis of Parkinsonism, 1893.
    Hostiuc S; Drima E; Buda O
    Front Neuroanat; 2016; 10():74. PubMed ID: 27445712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Georges Marinesco (1863-1938): neurologist, neurohistologist and neuropathologist.
    Catala M; Poirier J
    Rom J Morphol Embryol; 2012; 53(4):869-77. PubMed ID: 23303009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Édouard Brissaud, Fulgence Raymond and the succession of Charcot.
    Tatu L
    Front Neurol Neurosci; 2011; 29():52-60. PubMed ID: 20938146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Édouard Brissaud: distinguished neurologist and Charcot's pupil.
    Marques PT; Germiniani FMB; Camargo CHF; Munhoz RP; Teive HAG
    Arq Neuropsiquiatr; 2018 Jul; 76(7):490-493. PubMed ID: 30066801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Figures and institutions of the neurological sciences in Paris from 1800 to 1950. Part III: neurology.
    Broussolle E; Poirier J; Clarac F; Barbara JG
    Rev Neurol (Paris); 2012 Apr; 168(4):301-20. PubMed ID: 22387204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jean-Martin Charcot and Parkinson's disease: Teaching and teaching materials.
    Walusinski O
    Rev Neurol (Paris); 2018; 174(7-8):491-505. PubMed ID: 29653830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Georges Marinesco and the early research in neuropathology.
    Buda O; Arsene D; Ceausu M; Dermengiu D; Curca GC
    Neurology; 2009 Jan; 72(1):88-91. PubMed ID: 19122036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. George Marinesco in the Constellation of Modern Neuroscience.
    Opris I; Nestianu VS; Nestianu A; Bilteanu L; Ciurea J
    Front Neurosci; 2017; 11():726. PubMed ID: 29317856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Edouard Brissaud (1852-1909), Charcot's favorite pupil].
    Poirier J; Ricou P
    Hist Sci Med; 2010; 44(3):247-55. PubMed ID: 21560379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's 250th birthday.
    Lees AJ
    Mov Disord; 2007 Sep; 22 Suppl 17():S327-34. PubMed ID: 18175393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aphasia: debates].
    Roch Lecours A
    Rev Neurol (Paris); 1999 Oct; 155(10):833-47. PubMed ID: 10546298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers.
    Beach TG; Walker DG; Sue LI; Newell A; Adler CC; Joyce JN
    J Neuropathol Exp Neurol; 2004 Apr; 63(4):329-37. PubMed ID: 15099023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression marker of Parkinson's disease: a 4-year multi-site imaging study.
    Burciu RG; Ofori E; Archer DB; Wu SS; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
    Brain; 2017 Aug; 140(8):2183-2192. PubMed ID: 28899020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marinesco bodies and substantia nigra neuron density in Parkinson's disease.
    Abbott RD; Nelson JS; Ross GW; Uyehara-Lock JH; Tanner CM; Masaki KH; Launer LJ; White LR; Petrovitch H
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):621-630. PubMed ID: 28626918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theater in professor Charcot's galaxy.
    Poirier J; Philippon J
    Front Neurol Neurosci; 2013; 31():215-24. PubMed ID: 23485903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.